User profiles for Hannelore Ehrenreich
Hannelore EhrenreichClinical Neuroscience, Max Planck Institute of Experimental Medicine Verified email at em.mpg.de Cited by 45239 |
Specific attentional dysfunction in adults following early start of cannabis use
H Ehrenreich, T Rinn, HJ Kunert, MR Moeller… - …, 1999 - Springer
Rationale and objective: The present study tested the hypothesis that chronic interference by
cannabis with endogenous cannabinoid systems during peripubertal development causes …
cannabis with endogenous cannabinoid systems during peripubertal development causes …
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
…, R Heumann, A Cerami, H Ehrenreich… - Proceedings of the …, 2001 - National Acad Sciences
Erythropoietin (EPO) promotes neuronal survival after hypoxia and other metabolic insults
by largely unknown mechanisms. Apoptosis and necrosis have been proposed as …
by largely unknown mechanisms. Apoptosis and necrosis have been proposed as …
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain
…, W Poser, CH Gleiter, W Brück, H Ehrenreich - Acta …, 2001 - Springer
Using immunohistochemistry, expression of erythropoietin (EPO), a hypoxia-inducible
neuroprotective factor, and its receptor (EPOR) were investigated in human brain tissue after …
neuroprotective factor, and its receptor (EPOR) were investigated in human brain tissue after …
[HTML][HTML] Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system
Understanding the control of myelin formation by oligodendrocytes is essential for treating
demyelinating diseases. Neuregulin-1 (NRG1) type III, an EGF-like growth factor, is essential …
demyelinating diseases. Neuregulin-1 (NRG1) type III, an EGF-like growth factor, is essential …
[HTML][HTML] Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin
H Ehrenreich, D Hinze-Selch, S Stawicki, C Aust… - Molecular …, 2007 - nature.com
Schizophrenia is increasingly recognized as a neurodevelopmental disease with an additional
degenerative component, comprising cognitive decline and loss of cortical gray matter. …
degenerative component, comprising cognitive decline and loss of cortical gray matter. …
[HTML][HTML] Erythropoietin therapy for acute stroke is both safe and beneficial
H Ehrenreich, M Hasselblatt, C Dembowski, L Cepek… - Molecular …, 2002 - Springer
Background Erythropoietin (EPO) and its receptor play a major role in embryonic brain, are
weakly expressed in normal postnatal/adult brain and up-regulated upon metabolic stress. …
weakly expressed in normal postnatal/adult brain and up-regulated upon metabolic stress. …
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.
H Ehrenreich, RW Anderson, CH Fox… - The Journal of …, 1990 - rupress.org
Endothelins are peptides, originally isolated from endothelial cells, with potent vasoactive
and mitogenic properties. In this study, we demonstrate that human macrophages synthesize …
and mitogenic properties. In this study, we demonstrate that human macrophages synthesize …
Neuroligin‐3‐deficient mice: model of a monogenic heritable form of autism with an olfactory deficit
Autism spectrum disorder (ASD) is a frequent neurodevelopmental disorder characterized
by variable clinical severity. Core symptoms are qualitatively impaired communication and …
by variable clinical severity. Core symptoms are qualitatively impaired communication and …
Biological insights from 108 schizophrenia-associated genetic loci
…, S Cichon, A Darvasi, E Domenici, H Ehrenreich… - Nature, 2014 - nature.com
Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of
alleles, including common alleles of small effect that might be detected by genome-wide …
alleles, including common alleles of small effect that might be detected by genome-wide …
Recombinant human erythropoietin in the treatment of acute ischemic stroke
H Ehrenreich, K Weissenborn, H Prange, D Schneider… - Stroke, 2009 - Am Heart Assoc
Background and Purpose— Numerous preclinical findings and a clinical pilot study suggest
that recombinant human erythropoietin (EPO) provides neuroprotection that may be …
that recombinant human erythropoietin (EPO) provides neuroprotection that may be …